SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
SymBio Pharmaceuticals Announces Results Presented at American Society of Clinical Oncology 2012 Evaluating Clinical Benefits of TREAKISYM(R) (Bendamustine) in Combination With Rituximab in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)